Search research articles
Contact Us
Filters
Showing results (1-10 of 103) with videos related to
Page
of 11
Sort By:
European Urology
|
April 2, 2026
Reply to Therese Kang and Wee Loon Ong's Letter to the Editor re: Ragu Ratnakumaran, Douglas H. Brand, Archana Sasitharan, et al. Exploring Factors Associated with Late Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: Findings from the PACE-B Study. Eur Urol 2026;89:71-9
Ragu Ratnakumaran, Alison C Tree
Clinical and Translational Radiation Oncology
|
July 26, 2019
Prostate cancer - Advantages and disadvantages of MR-guided RT
Julia Murray, Alison C Tree
International Journal of Radiation Oncology, Biology, Physics
|
October 18, 2020
Commentary on Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer
Katie L Spencer, Alison C Tree
International Journal of Radiation Oncology, Biology, Physics
|
July 17, 2022
Fractionation Choice for Elective Lymph Node Radiation Therapy in Prostate Cancer: Slightly More to CHIRP About
Douglas H Brand, Alison C Tree
European Urology
|
June 24, 2017
Re: Declan G. Murphy, Christopher J. Sweeney, Bertrand Tombal. "Gotta Catch 'em All" or Do We? Pokemet Approach to Metastatic Prostate Cancer. Eur Urol 2017;72:1-3
Alison C Tree, Shankar Siva, Piet Ost
Nature Reviews. Urology
|
April 22, 2021
Single dose prostate radiotherapy - a step too far?
Alison C Tree, Nicholas J van As
The Lancet. Oncology
|
October 2, 2025
Toxicity assessment bias in the PACE-C trial - Authors' reply
Alison C Tree, Emma Hall, Nicholas Vas As
The Lancet. Oncology
|
March 4, 2021
Intermediate clinical endpoints in localised prostate cancer
Alison C Tree, David P Dearnaley, Emma Hall
Cancer Journal (Sudbury, Mass.)
|
August 6, 2025
Harnessing Radiation Biology to Increase Cancer Cure Rates
Kevin J Harrington, Saptha Veerapathiran, Alison C Tree
Current Oncology Reports
|
March 27, 2017
The Role of Hypofractionated Radiotherapy in Prostate Cancer
Linus C Benjamin, Alison C Tree, David P Dearnaley
Page
of 11
Search research articles
Search
Showing results (1-10 of 103) with videos related to
Sort By:
Page
of 11
European Urology
|
April 2, 2026
Reply to Therese Kang and Wee Loon Ong's Letter to the Editor re: Ragu Ratnakumaran, Douglas H. Brand, Archana Sasitharan, et al. Exploring Factors Associated with Late Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: Findings from the PACE-B Study. Eur Urol 2026;89:71-9
Ragu Ratnakumaran, Alison C Tree
Clinical and Translational Radiation Oncology
|
July 26, 2019
Prostate cancer - Advantages and disadvantages of MR-guided RT
Julia Murray, Alison C Tree
International Journal of Radiation Oncology, Biology, Physics
|
October 18, 2020
Commentary on Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer
Katie L Spencer, Alison C Tree
International Journal of Radiation Oncology, Biology, Physics
|
July 17, 2022
Fractionation Choice for Elective Lymph Node Radiation Therapy in Prostate Cancer: Slightly More to CHIRP About
Douglas H Brand, Alison C Tree
European Urology
|
June 24, 2017
Re: Declan G. Murphy, Christopher J. Sweeney, Bertrand Tombal. "Gotta Catch 'em All" or Do We? Pokemet Approach to Metastatic Prostate Cancer. Eur Urol 2017;72:1-3
Alison C Tree, Shankar Siva, Piet Ost
Nature Reviews. Urology
|
April 22, 2021
Single dose prostate radiotherapy - a step too far?
Alison C Tree, Nicholas J van As
The Lancet. Oncology
|
October 2, 2025
Toxicity assessment bias in the PACE-C trial - Authors' reply
Alison C Tree, Emma Hall, Nicholas Vas As
The Lancet. Oncology
|
March 4, 2021
Intermediate clinical endpoints in localised prostate cancer
Alison C Tree, David P Dearnaley, Emma Hall
Cancer Journal (Sudbury, Mass.)
|
August 6, 2025
Harnessing Radiation Biology to Increase Cancer Cure Rates
Kevin J Harrington, Saptha Veerapathiran, Alison C Tree
Current Oncology Reports
|
March 27, 2017
The Role of Hypofractionated Radiotherapy in Prostate Cancer
Linus C Benjamin, Alison C Tree, David P Dearnaley
Page
of 11